Blood–brain barrier remodeling during brain metastasis formation

Molecular Medicine

Volumn 22, Issue , 2016, Pages 32-40

  Wrobel, Jagoda K ^a   Toborek, Michal ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b INSTITUTE OF SPORT SCIENCES   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD BRAIN BARRIER; BRAIN CIRCULATION; BRAIN METASTASIS; CANCER GROWTH; CARCINOGENESIS; CELL HOMING; CELL MIGRATION; CELL MOTION; CELL SURVIVAL; EXTRAVASATION; HUMAN; INTRAVASATION; PRIORITY JOURNAL; REVIEW; TUMOR CELL; TUMOR INVASION; TUMOR MICROENVIRONMENT; VASCULAR ENDOTHELIUM;

EID: 84987681535     PISSN: 10761551     EISSN: 15283658     Source Type: Journal    
DOI: 10.2119/molmed.2015.00207     Document Type: Review

References (83)

1. Macconaill LE, Garraway LA. (2010) Clinical implications of the cancer genome. J. Clin. Oncol. 28:5219–28.
2. Farmer P, et al. (2010) Expansion of cancer care and control in countries of low and middle income: a call to action. Lancet. 376:1186–93.
3. Hanahan D, Weinberg RA. (2011) Hallmarks of cancer: the next generation. Cell. 144:646–74.
4. Chambers AF, Groom AC, MacDonald IC. (2002) Dissemination and growth of cancer cells in metastatic sites. Nat. Rev. Cancer. 2:563–72.
5. Valastyan S, Weinberg RA. (2011) Tumor metastasis: molecular insights and evolving paradigms. Cell. 147:275–92.
6. Labelle M, Hynes RO. (2012) The initial hours of metastasis: the importance of cooperative host-tumor cell interactions during hematogenous dissemination. Cancer Discov. 2:1091–9.
7. van Zijl F, Krupitza G, Mikulits W. (2011) Initial steps of metastasis: cell invasion and endothelial transmigration. Mutat. Res. 728:23–34.
8. Nguyen DX, Bos PD, Massague J. (2009) Metastasis: from dissemination to organ-specific colonization. Nat. Rev. Cancer. 9:274–84.
9. Hunter K. (2015) The role of individual inheritance in tumor progression and metastasis. J. Mol. Med. (Berl). 93:719–25.
10. Sahai E. (2007) Illuminating the metastatic process. Nat. Rev. Cancer. 7:737–49.
11. Kim JW, et al. (2004) Rapid apoptosis in the pulmonary vasculature distinguishes non-metastatic from metastatic melanoma cells. Cancer Lett. 213:203–12.
12. Fidler IJ. (2003) The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nat. Rev. Cancer. 3:453–8.
13. Chaffer CL, Weinberg RA. (2011) A perspective on cancer cell metastasis. Science. 331:1559–64.
14. Friedl P, Wolf K. (2003) Tumour-cell invasion and migration: diversity and escape mechanisms. Nat. Rev. Cancer. 3:362–74.
15. Friedl P, Alexander S. (2011) Cancer invasion and the microenvironment: plasticity and reciprocity. Cell. 147:992–1009.
16. Kessenbrock K, Plaks V, Werb Z. (2010) Matrix metalloproteinases: regulators of the tumor microenvironment. Cell. 141:52–67.
17. Hu L, et al. (2010) Biological characteristics of a specific brain metastatic cell line derived from human lung adenocarcinoma. Med. Oncol. 27:708–14.
18. Mendes O, Kim HT, Stoica G. (2005) Expression of MMP2, MMP9 and MMP3 in breast cancer brain metastasis in a rat model. Clin. Exp. Metastasis. 22:237–46.
19. Xie TX, et al. (2006) Activation of stat3 in human melanoma promotes brain metastasis. Cancer Res. 66:3188–96.
20. Feng S, et al. (2011) Matrix metalloproteinase-2 and -9 secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight junction proteins. PLoS One. 6:e20599.
21. Yang Y, Rosenberg GA. (2011) MMP-mediated disruption of claudin-5 in the blood-brain barrier of rat brain after cerebral ischemia. Methods Mol. Biol. 762:333–45.
22. Fazakas C, et al. (2011) Transmigration of melanoma cells through the blood-brain barrier: role of endothelial tight junctions and melanoma-released serine proteases. PLoS One. 6:e20758.
23. Joyce JA, Pollard JW. (2009) Microenvironmental regulation of metastasis. Nat. Rev. Cancer. 9:239–52.
24. Deryugina EI, Quigley JP. (2015) Tumor angiogenesis: MMP-mediated induction of intravasation- and metastasis-sustaining neovasculature. Matrix Biol. 44–46C:94–112.
25. Reymond N, d’Agua BB, Ridley AJ. (2013) Crossing the endothelial barrier during metastasis. Nat. Rev. Cancer. 13:858–70.
26. Khuon S, et al. (2010) Myosin light chain kinase mediates transcellular intravasation of breast cancer cells through the underlying endothelial cells: a three-dimensional FRET study. J. Cell Sci. 123:431–40.
27. Goubran HA, Stakiw J, Radosevic M, Burnouf T. (2014) Platelets effects on tumor growth. Semin. Oncol. 41:359–69.
28. Lee TH, Avraham HK, Jiang S, Avraham S. (2003) Vascular endothelial growth factor modulates the transendothelial migration of MDA-MB-231 breast cancer cells through regulation of brain microvascular endothelial cell permeability. J. Biol. Chem. 278:5277–84.
29. Leong HS, et al. (2014) Invadopodia are required for cancer cell extravasation and are a therapeutic target for metastasis. Cell Rep. 8:1558–70.
30. Wels J, Kaplan RN, Rafii S, Lyden D. (2008) Migratory neighbors and distant invaders: tumor-associated niche cells. Genes Dev. 22:559–74.
31. Wilhelm I, Molnar J, Fazakas C, Hasko J, Krizbai IA. (2013) Role of the blood-brain barrier in the formation of brain metastases. Int. J. Mol. Sci. 14:1383–411.
32. Lorger M, Felding-Habermann B. (2010) Capturing changes in the brain microenvironment during initial steps of breast cancer brain metastasis. Am. J. Pathol. 176:2958–71.
33. Paku S, Dome B, Toth R, Timar J. (2000) Organ-specificity of the extravasation process: an ultrastructural study. Clin. Exp. Metastasis. 18:481–92.
34. Kienast Y, et al. (2010) Real-time imaging reveals the single steps of brain metastasis formation. Nat. Med. 16:116–22.
35. JuanYin J, et al. (2009) Noninvasive imaging of the functional effects of anti-VEGF therapy on tumor cell extravasation and regional blood volume in an experimental brain metastasis model. Clin. Exp. Metastasis. 26:403–14.
36. Hanibuchi M, Kim SJ, Fidler IJ, Nishioka Y. (2014) The molecular biology of lung cancer brain metastasis: an overview of current comprehensions and future perspectives. J. Med. Invest. 61:241–53.
37. Miles FL, Pruitt FL, van Golen KL, Cooper CR. (2008) Stepping out of the flow: capillary extravasation in cancer metastasis. Clin. Exp. Metastasis. 25:305–24.
38. Ravindranath MH, et al. (1997) Endothelial-selectin ligands sialyl Lewis(x) and sialyl Lewis(a) are differentiation antigens immunogenic in human melanoma. Cancer. 79:1686–97.
39. Ghislin S, et al. (2012) LFA-1 and ICAM-1 expression induced during melanoma-endothelial cell co-culture favors the transendothelial migration of melanoma cell lines in vitro. BMC Cancer. 12:455.
40. Klemke M, Weschenfelder T, Konstandin MH, Samstag Y. (2007) High affinity interaction of integrin alpha4beta1 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) enhances migration of human melanoma cells across activated endothelial cell layers. J. Cell. Physiol. 212:368–74.
41. Fritzsche J, Simonis D, Bendas G. (2008) Melanoma cell adhesion can be blocked by heparin in vitro: suggestion of VLA-4 as a novel target for antimetastatic approaches. Thromb. Haemost. 100:1166–75.
42. Huh SJ, Liang S, Sharma A, Dong C, Robertson GP. (2010) Transiently entrapped circulating tumor cells interact with neutrophils to facilitate lung metastasis development. Cancer Res. 70:6071–82.
43. Avraham HK, et al. (2014) Angiopoietin-2 mediates blood-brain barrier impairment and colonization of triple-negative breast cancer cells in brain. J. Pathol. 232:369–81.
44. Sevenich L, et al. (2014) Analysis of tumour- and stroma-supplied proteolytic networks reveals a brain-metastasis-promoting role for cathepsin S. Nat. Cell. Biol. 16:876–88.
45. Yoshimasu T, et al. (2004) Increased expression of integrin alpha3beta1 in highly brain metastatic subclone of a human non-small cell lung cancer cell line. Cancer Sci. 95:142–8.
46. Voura EB, Ramjeesingh RA, Montgomery AM, Siu CH. (2001) Involvement of integrin alpha(v) beta(3) and cell adhesion molecule L1 in transendothelial migration of melanoma cells. Mol. Biol. Cell. 12:2699–710.
47. Malin D, et al. (2014) alphaB-crystallin: a novel regulator of breast cancer metastasis to the brain. Clin. Cancer Res. 20:56–67.
48. Tominaga N, et al. (2015) Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood-brain barrier. Nat. Commun. 6:6716.
49. Gligorijevic B, et al. (2012) N-WASP-mediated invadopodium formation is involved in intravasation and lung metastasis of mammary tumors. J. Cell Sci. 125:724–34.
50. Lorger M, Krueger JS, O’Neal M, Staflin K, Felding-Habermann B. (2009) Activation of tumor cell integrin alphavbeta3 controls angiogenesis and metastatic growth in the brain. Proc. Natl. Acad. Sci. U. S. A. 106:10666–71.
51. Cho JH, et al. (2015) AKT1 activation promotes development of melanoma metastases. Cell Rep. 13:898–905.
52. Nanni P, et al. (2012) Multiorgan metastasis of human HER-2+ breast cancer in Rag2-/-; Il2rg-/-mice and treatment with PI3K inhibitor. PLoS One. 7:e39626.
53. Molnar J, et al. (2015) Transmigration characteristics of breast cancer and melanoma cells through the brain endothelium: role of Rac and PI3K. Cell Adh. Migr. 8 December 2015 [Epub ahead of print]
54. Oku T, et al. (1998) Tumor growth modulation by sense and antisense vascular endothelial growth factor gene expression: effects on angiogenesis, vascular permeability, blood volume, blood flow, fluorodeoxyglucose uptake, and proliferation of human melanoma intracerebral xenografts. Cancer Res. 58:4185–92.
55. Yano S, et al. (2000) Expression of vascular endothelial growth factor is necessary but not sufficient for production and growth of brain metastasis. Cancer Res. 60:4959–67.
56. Ba JL, Jandial R, Nesbit A, Badie B, Chen M. (2015) Current and emerging treatments for brain metastases. Oncology (Williston Park). 29:250–7.
57. Soto MS, Serres S, Anthony DC, Sibson NR. (2014) Functional role of endothelial adhesion molecules in the early stages of brain metastasis. Neuro. Oncol. 16:540–51.
58. Eichler AF, et al. (2011) The biology of brain metastases: translation to new therapies. Nat. Rev. Clin. Oncol. 8:344–56.
59. Fidler IJ, Yano S, Zhang RD, Fujimaki T, Bucana CD. (2002) The seed and soil hypothesis: vascularisation and brain metastases. Lancet Oncol. 3:53–7.
60. Fidler IJ. (2011) The role of the organ microenvironment in brain metastasis. Semin. Cancer Biol. 21:107–12.
61. Jia W, Martin TA, Zhang G, Jiang WG. (2013) Junctional adhesion molecules in cerebral endothelial tight junction and brain metastasis. Anticancer Res. 33:2353–9.
62. Huber JD, Egleton RD, Davis TP. (2001) Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier. Trends Neurosci. 24:719–25.
63. Abbott NJ, Ronnback L, Hansson E. (2006) Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 7:41–53.
64. Rolland Y, Demeule M, Fenart L, Beliveau R. (2009) Inhibition of melanoma brain metastasis by targeting melanotransferrin at the cell surface. Pigment Cell Melanoma Res. 22:86–98.
65. Bos PD, et al. (2009) Genes that mediate breast cancer metastasis to the brain. Nature. 459:1005–9.
66. Gabos Z, et al. (2006) Prognostic significance of human epidermal growth factor receptor positivity for the development of brain metastasis after newly diagnosed breast cancer. J. Clin. Oncol. 24:5658–63.
67. Minn AJ, et al. (2005) Genes that mediate breast cancer metastasis to lung. Nature. 436:518–24.
68. Grinberg-Rashi H, et al. (2009) The expression of three genes in primary non-small cell lung cancer is associated with metastatic spread to the brain. Clin. Cancer Res. 15:1755–61.
69. Nakashima T, et al. (2003) Neural-cadherin expression associated with angiogenesis in non-small-cell lung cancer patients. Br. J. Cancer. 88:1727–33.
70. Yoo J, et al. (2012) Immunohistochemical expression of DCUN1D1 in non-small cell lung carcinoma: its relation to brain metastasis. Cancer Res. Treat. 44:57–62.
71. Winkler F. (2015) The brain metastatic niche. J. Mol. Med. (Berl.). 93:1213–20.
72. Marchetti D, Li J, Shen R. (2000) Astrocytes contribute to the brain-metastatic specificity of melanoma cells by producing heparanase. Cancer Res. 60:4767–70.
73. Seike T, et al. (2011) Interaction between lung cancer cells and astrocytes via specific inflammatory cytokines in the microenvironment of brain metastasis. Clin. Exp. Metastasis. 28:13–25.
74. Valiente M, et al. (2014) Serpins promote cancer cell survival and vascular co-option in brain metastasis. Cell. 156:1002–16.
75. Louie E, et al. (2013) Neurotrophin-3 modulates breast cancer cells and the microenvironment to promote the growth of breast cancer brain metastasis. Oncogene. 32:4064–77.
76. Neman J, et al. (2014) Human breast cancer metastases to the brain display GABAergic properties in the neural niche. Proc. Natl. Acad. Sci. U. S. A. 111:984–9.
77. Yonemori K, et al. (2010) Disruption of the blood brain barrier by brain metastases of triple-negative and basal-type breast cancer but not HER2/ neu-positive breast cancer. Cancer. 116:302–8.
78. Wanek T, et al. (2015) Factors governing P-glycoprotein-mediated drug-drug interactions at the blood-brain barrier measured with positron emission tomography. Mol. Pharm. 12:3214–25.
79. Cannon RE, Peart JC, Hawkins BT, Campos CR, Miller DS. (2012) Targeting blood-brain barrier sphingolipid signaling reduces basal P-glycoprotein activity and improves drug delivery to the brain. Proc. Natl. Acad. Sci. U. S. A. 109:15930–5.
80. de Vries NA, et al. (2007) P-glycoprotein and breast cancer resistance protein: two dominant transporters working together in limiting the brain penetration of topotecan. Clin. Cancer Res. 13:6440–9.
81. Lemos C, Jansen G, Peters GJ. (2008) Drug transporters: recent advances concerning BCRP and tyrosine kinase inhibitors. Br. J. Cancer. 98:857–62.
82. Ni Z, Bikadi Z, Rosenberg MF, Mao Q. (2010) Structure and function of the human breast cancer resistance protein (BCRP/ABCG2). Curr. Drug Metab. 11:603–17.
83. Kodaira H, Kusuhara H, Ushiki J, Fuse E, Sugiyama Y. (2010) Kinetic analysis of the cooperation of P-glycoprotein (P-gp/Abcb1) and breast cancer resistance protein (Bcrp/Abcg2) in limiting the brain and testis penetration of erlotinib, flavopiridol, and mitoxantrone. J. Pharmacol. Exp. Ther. 333:788–96.